Alliancebernstein L.P. Surmodics Inc Transaction History
Alliancebernstein L.P.
- $261 Billion
- Q1 2025
A detailed history of Alliancebernstein L.P. transactions in Surmodics Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 849,354 shares of SRDX stock, worth $29.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
849,354
Previous 1,011,262
16.01%
Holding current value
$29.8 Million
Previous $40 Million
35.25%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding SRDX
# of Institutions
144Shares Held
12.1MCall Options Held
31.3KPut Options Held
17.9K-
Black Rock Inc. New York, NY1.17MShares$41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA799KShares$28 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT789KShares$27.6 Million1.99% of portfolio
-
Morgan Stanley New York, NY676KShares$23.7 Million0.0% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT465KShares$16.3 Million0.05% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $491M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...